Evidence map›Paper›PMID 41680266›Full record

ArticleCommunications biology2026

Nanopore sequencing reveals hidden landscape of short L1 transductions in colorectal cancer.

Päivi Nummi, Aurora Taira, Janne Ravantti, Tuukka Norri, Niko Välimäki, Anna Lepistö, Laura Renkonen-Sinisalo, Selja Koskensalo, Toni T Seppälä, Ari Ristimäki and 12 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Päivi NummiApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8058-0783
Aurora TairaApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1179-8500
Janne RavanttiApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8578-7230
Tuukka NorriApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8276-0585
Niko VälimäkiApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-9200-9560
Anna LepistöDepartment of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Laura Renkonen-SinisaloDepartment of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Selja KoskensaloDepartment of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-6959-8715
Toni T SeppäläApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-4940-3498
Ari RistimäkiApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-5373-9234
Kyösti TahkolaDepartment of Surgery, Wellbeing Services County of Central Finland/Hospital Nova of Central Finland, Jyväskylä, Finland.ORCID http://orcid.org/0000-0002-1626-5690
Anne MattilaDepartment of Surgery, Wellbeing Services County of Central Finland/Hospital Nova of Central Finland, Jyväskylä, Finland.
Jan BöhmDepartment of Surgery, Wellbeing Services County of Central Finland/Hospital Nova of Central Finland, Jyväskylä, Finland.
Jukka-Pekka MecklinDepartment of Education and Research, Well Being Services County of Central Finland, Jyväskylä, Finland.
Emma SiiliDepartment of Pathology, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Annukka PasanenDepartment of Pathology, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Oskari HeikinheimoDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8671-130X
Ralf BützowDepartment of Pathology, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-4366-5099
Auli KarhuApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-7927-0796
Lauri A AaltonenApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-6839-4286
Kimmo PalinApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. kimmo.palin@helsinki.fi.ORCID http://orcid.org/0000-0002-4621-6128
Tatiana CajusoDepartment of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. tatiana.cajuso@helsinki.fi.ORCID http://orcid.org/0000-0002-6354-5572

Funding

Syöpäsäätiö (Cancer Foundation Finland) 230068, 200071Wellcome Trust 220001
6 · The paper itself

Abstract

L1s are repetitive sequences capable of copying themselves into new genomic loci. While L1s are typically repressed by DNA methylation in somatic tissues, they can become reactivated in cancer. Although L1 sequences are highly repetitive, ~25% of insertions carry a unique downstream sequence, transduction, that can be used to trace the source L1. Here, we apply nanopore long-read sequencing to 56 colorectal cancer samples to comprehensively detect somatic transductions and to characterize the source L1 activity. We demonstrate that earlier methods systematically miss a large proportion of mostly shorter transductions, leading to an incomplete and biased view of source L1 activity. Our analysis reveals a strong positive correlation between the number of transductions and other L1 insertions within samples and that distinct source L1s exhibit varying transduction lengths and 5' inversion frequency. Finally, we integrate DNA methylation provided by nanopore reads and show that active elements in cancer samples have lower methylation levels in contrast to inactive L1s. Together, our results provide a more complete characterization of somatically active L1 elements in colorectal cancer and highlight the utility of long-read sequencing in retrotransposon research.

Indexed as

Colorectal NeoplasmsLong Interspersed Nucleotide ElementsNanopore SequencingDNA MethylationHumans

Identifiers

PMID41680266
PMCPMC13009371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.